Quality of Life and Symptom Management in Patients With Bladder Cancer

Assessment of Supportive Care and Educational Needs to Guide Quality Care Improvements for Patients With Locally Advanced and Metastatic Bladder Cancer

NCT06412874 ·Status: COMPLETED

Markers of Response to Intravesical Bladder Cancer Therapy

NCT01007058 ·Status: COMPLETED

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

NCT03413982 ·Status: RECRUITING

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

NCT04701918 ·Status: COMPLETED ·Phase: PHASE2

The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life

NCT05195515 ·Status: ENROLLING_BY_INVITATION

Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer

NCT01627197 ·Status: COMPLETED ·Phase: PHASE3

Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer

NCT02688348 ·Status: WITHDRAWN ·Phase: NA

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

NCT01050504 ·Status: RECRUITING

Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer

NCT01373294 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

NCT05137262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

NCT05687721 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Prognostic Biomarkers in Patients With Urothelial Carcinoma

NCT04872036 ·Status: COMPLETED

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

NCT05327647 ·Status: RECRUITING ·Phase: PHASE2

An Expanded Access Study of Bemarituzumab (FPA144) for a Single Patient With Recurrent Bladder Cancer

NCT03801278 ·Status: NO_LONGER_AVAILABLE

Multidisciplinary Bladder-preservation Therapy for Bladder Cancer

NCT03756207 ·Status: UNKNOWN ·Phase: NA

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

NCT03317158 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

NCT02145390 ·Status: TERMINATED ·Phase: NA

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

NCT07225127 ·Status: RECRUITING

Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy

NCT06986304 ·Status: RECRUITING

Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients

NCT05739968 ·Status: RECRUITING ·Phase: NA

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

NCT06637423 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

NCT01410565 ·Status: TERMINATED ·Phase: PHASE3

Personalized Urine Biomarker for Patients With Bladder Cancer

NCT05467267 ·Status: UNKNOWN

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05136898 ·Status: COMPLETED ·Phase: PHASE3

The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer

NCT02716623 ·Status: COMPLETED ·Phase: NA